Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.10. rezultāts no 100.
457. lappuse
... satisfactory if it is not less than 0.8 and not more than 1.8 . ( 2 ) Efficiency of the column . From the number of theoretical plates ( n ) cal- culated as described in §436.216 ( c ) ( 2 ) calculate the reduced plate height ( h ...
... satisfactory if it is not less than 0.8 and not more than 1.8 . ( 2 ) Efficiency of the column . From the number of theoretical plates ( n ) cal- culated as described in §436.216 ( c ) ( 2 ) calculate the reduced plate height ( h ...
463. lappuse
... satisfactory when determined by the method de- scribed in this paragraph if it is not less than 85 percent of that which it is represented to contain . ( c ) Procaine penicillin . The procaine penicillin content of the batch is the ...
... satisfactory when determined by the method de- scribed in this paragraph if it is not less than 85 percent of that which it is represented to contain . ( c ) Procaine penicillin . The procaine penicillin content of the batch is the ...
465. lappuse
... satisfactory if it contains not less than 85 percent of that which it is represented to contain . ( 2 ) Procaine penicillin content ( except for single - dose containers ) . Make suit- able dilutions of the solution prepared in ...
... satisfactory if it contains not less than 85 percent of that which it is represented to contain . ( 2 ) Procaine penicillin content ( except for single - dose containers ) . Make suit- able dilutions of the solution prepared in ...
467. lappuse
... satisfactory if it contains not less than 85 percent of the number of units per milliliter or per gram that it is rep- resented to contain . ( 2 ) Streptomycin content . Proceed as directed in §544.373 ( b ) ( 1 ) ( 1 ) of this chap ...
... satisfactory if it contains not less than 85 percent of the number of units per milliliter or per gram that it is rep- resented to contain . ( 2 ) Streptomycin content . Proceed as directed in §544.373 ( b ) ( 1 ) ( 1 ) of this chap ...
468. lappuse
... satisfactory if it contains not less than 85 percent of the number of milligrams that it is represented to contain . ( 3 ) Dihydrostreptomycin content . Pro- ceed as directed in paragraph ( a ) ( 2 ) of this section , using the ...
... satisfactory if it contains not less than 85 percent of the number of milligrams that it is represented to contain . ( 3 ) Dihydrostreptomycin content . Pro- ceed as directed in paragraph ( a ) ( 2 ) of this section , using the ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning